| Financial Year |
March 31 2023 |
| Monetary Funds |
9,621,393,263.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,386,361,199.60 |
| Accounts Receivable |
3,079,654,138.57 |
| Advances to Suppliers |
1,523,776,223.10 |
| Other Receivables |
83,660,169.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,011,980,700.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,005,546,681.30 |
| Total Current Assets |
32,798,531,431.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,543,301.34 |
| Investment Properties |
56,875,174.75 |
| Fixed Assetes |
2,614,007,550.30 |
| Under-construction Projects |
1,405,880,905.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,531,197,065.47 |
| R&D expenses |
4,689,356,468.30 |
| Goodwill |
21,268,668.34 |
| Long-Term Deferred and Prepaid Expenses |
40,326,869.70 |
| Deferred Income Tax Assets |
378,981,272.01 |
| Other Non-Current Assets |
93,728,280.12 |
| Sub-Total of Non-Current Assets |
12,055,728,910.47 |
| Total Assets |
44,854,260,342.31 |
| Short-Term Loans |
15,130,075.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
453,162,446.39 |
| Accounts Payable |
6,232,669,979.86 |
| Accounts Received In Advance |
55,045,980.43 |
| Employee Compensation Payable |
503,101,281.29 |
| Taxes Payable |
95,038,925.17 |
| Interest Payable |
2,029,169.75 |
| Dividend Payable |
245,990,423.72 |
| Other payables |
411,473,986.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,779,811.32 |
| Other Current Liabilities |
1,101,509,752.39 |
| Sub-Total of Current Liabilities |
16,719,339,837.20 |
| Long-term Loans |
4,440,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,700,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,121,870.14 |
| Other Non-Current Liabilities |
20,605.20 |
| Sub-Total of Non-Current Liabilities |
7,488,238,061.68 |
| Total Liabilities |
24,207,577,898.88 |
| Paid-In Capital(Or Share Stock) |
529,560,089.00 |
| Capital Surplus |
14,121,381,710.04 |
| Surplus Reserve |
81,340,981.45 |
| LESS:Treasury Stock |
90,451,389.00 |
| Undistributed Profits |
5,750,859,281.73 |
| Minority Stockholder's Interest |
261,468,327.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,385,214,116.26 |
| Owner's Equity（Stockholder's Equity） |
20,646,682,443.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,854,260,342.31 |
